Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

被引：1104

作者：

Presta, M ^{[1
]}

Dell'Era, P ^{[1
]}

Mitola, S ^{[1
]}

Moroni, E ^{[1
]}

Ronca, R ^{[1
]}

Rusnati, M ^{[1
]}

机构：

[1] Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Unit Gen Pathol & Immunol, I-25123 Brescia, Italy

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2005年 / 16卷 / 02期

关键词：

angiogenesis; endothelium; FGF; FGF receptors; tumor;

D O I：

10.1016/j.cytogfr.2005.01.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Fibroblast growth factors (FGFs) are a family of heparin-binding growth factors. FGFs exert their pro-angiogenic activity by interacting with various endothelial cell surface receptors, including tyrosine kinase receptors, heparan-sulfate proteoglycans, and integrins. Their activity is modulated by a variety of free and extracellular matrix-associated molecules. Also, the cross-talk among FGFs, vascular endothelial growth factors (VEGFs), and inflammatory cytokines/chemokines may play a role in the modulation of blood vessel growth in different pathological conditions, including cancer. Indeed, several experimental evidences point to a role for FGFs in tumor growth and angiogenesis. This review will focus on the relevance of the FGF/FGF receptor system in adult angiogenesis and its contribution to tumor vascularization. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：159 / 178

页数：20

共 259 条

[11] DIFFERENTIAL MODULATION OF CELL PHENOTYPE BY DIFFERENT MOLECULAR-WEIGHT FORMS OF BASIC FIBROBLAST GROWTH-FACTOR - POSSIBLE INTRACELLULAR SIGNALING BY THE HIGH-MOLECULAR-WEIGHT FORMS
BIKFALVI, A
KLEIN, S
PINTUCCI, G
QUARTO, N
MIGNATTI, P
RIFKIN, DB
[J]. JOURNAL OF CELL BIOLOGY, 1995, 129 (01) : 233 - 243
[12] Role of tumor-associated gangliosides in cancer progression
Birklé, S
Zeng, G
Gao, L
Yu, RK
Aubry, J
[J]. BIOCHIMIE, 2003, 85 (3-4) : 455 - 463
[13] T-LYMPHOCYTES SYNTHESIZE AND EXPORT HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR, MITOGENS FOR VASCULAR CELLS AND FIBROBLASTS - DIFFERENTIAL PRODUCTION AND RELEASE BY CD4+ AND CD8+ T-CELLS
BLOTNICK, S
PEOPLES, GE
FREEMAN, MR
EBERLEIN, TJ
KLAGSBRUN, M
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) : 2890 - 2894
[14] Thrombospondin 2, a matricellular protein with diverse functions
Bornstein, P
Armstrong, LC
Hankenson, KD
Kyriakides, TR
Yang, ZT
[J]. MATRIX BIOLOGY, 2000, 19 (07) : 557 - 568
[15] Antiangiogenic properties of fibstatin, an extracellular FGF-2-binding polypeptide
Bossard, C
Van den Berghe, L
Laurell, H
Castano, C
Cerutti, M
Prats, AC
Prats, H
[J]. CANCER RESEARCH, 2004, 64 (20) : 7507 - 7512
[16] Multimer formation and ligand recognition by the long pentraxin PTX3 - Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component
Bottazzi, B
Vouret-Craviari, V
Bastone, A
De Gioia, L
Matteucci, C
Peri, G
Spreafico, F
Pausa, M
D'Ettorre, C
Gianazza, E
Tagliabue, A
Salmona, M
Tedesco, F
Introna, M
Mantovani, A
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) : 32817 - 32823
[17] BREVIARIO F, 1992, J BIOL CHEM, V267, P22190
[18] HISTIDINE-RICH GLYCOPROTEIN AND PLATELET FACTOR-4 MASK HEPARAN-SULFATE PROTEOGLYCANS RECOGNIZED BY ACIDIC AND BASIC FIBROBLAST GROWTH-FACTOR
BROWN, KJ
PARISH, CR
[J]. BIOCHEMISTRY, 1994, 33 (46) : 13918 - 13927
[19] BRUSTLE O, 1992, ONCOGENE, V7, P1177
[20] Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2
Cao, RH
Bråkenhielm, E
Pawliuk, R
Wariaro, D
Post, MJ
Wahlberg, E
Leboulch, P
Cao, YH
[J]. NATURE MEDICINE, 2003, 9 (05) : 604 - 613

← 1 2 3 4 5 6 7 8 9 10 →